市場調査レポート

商品コード

1452781

下大静脈フィルターの世界市場規模、シェア、成長分析、製品タイプ別、配置別 - 産業予測2024～2031年

Global Inferior Vena Cava Filters Market Size, Share, Growth Analysis, By Product Type(Retrievable Filters and Permanent Filters), By Placement(Permanent Placement, Temporary Placement) - Industry Forecast 2024-2031

出版日: 2024年03月09日 | 発行: SkyQuest

| ページ情報: 英文 219 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 836,870円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 978,980円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,121,090円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.90円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の下大静脈フィルターの市場規模は、2022年に7億8,360万米ドルとなり、2023年の8億4,966万米ドルから、2031年までには16億2,345万米ドルに成長し、予測期間（2024～2031年）のCAGRは8.43％で成長する見通しです。

下大静脈（IVC）フィルター市場は、血栓が肺に到達する前に阻止することで、血栓に関連する生命を脅かす状況を回避する上で重要な役割を果たしています。これらの医療機器は、血栓を捕捉し、肺塞栓症のリスクを軽減する目的で、下半身から心臓へ脱酸素血液を送る主要な静脈である下大静脈に挿入されます。市場の拡大には、静脈血栓塞栓症（VTE）や深部静脈血栓症（DVT）の有病率の上昇と、これらの疾患に対する意識の高まりが寄与しています。高齢化、座りがちなライフスタイル、外科的介入など様々な要因が血液凝固リスクの高まりに寄与しており、IVCフィルターの需要を押し上げています。回収可能で調節可能なフィルター設計を含む技術的進歩は、その有効性と安全性を増強し、それによって市場の成長を促進します。さらに、低侵襲手術の採用増加や医療用画像診断技術の進歩により、正確なフィルター設置が容易になったことも、市場の利益となっています。北米は強固なヘルスケアインフラとVTE罹患率の高さにより市場を独占しており、アジア太平洋は医療費と意識の高まりにより急成長を遂げています。また、高齢化が進む欧州も大きな市場シェアを占めています。IVCフィルター技術の革新が進み、ハイリスク患者への採用が増加していることから、血栓に関連する合併症を予防し、患者の転帰を向上させるという重要な必要性に対処する上で、同市場は有利な立場にあります。

技術分析
価格分析
サプライチェーン分析
バリューチェーン分析
市場のエコシステム
IP分析
貿易分析
スタートアップ分析
原材料の分析
イノベーションマトリクス
パイプライン製品の分析
マクロ経済指標
主な投資の分析
主な成功要因
競合の程度

市場力学と見通し

市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
規制情勢
ポーターの分析
将来の混乱についての特別な考察

下大静脈フィルターの世界市場：製品タイプ別

市場概要
回収可能フィルター・永久フィルター

下大静脈フィルターの世界市場：配置別

市場概要
永久配置
一時的配置

下大静脈フィルターの世界市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2021年）
主な市場企業が採用した戦略
主要成功戦略
市場における最近の活動
主要企業の市場シェア（2021年）

主要企業プロファイル

Boston Scientific Corporation
Cook Medical
Cordis Corporation（a Cardinal Health company）
B. Braun Melsungen AG
C.R. Bard, Inc.（acquired by BD）
Johnson & Johnson
Medtronic plc
Abbott Laboratories
Terumo Corporation
Becton, Dickinson and Company（BD）
Merit Medical Systems, Inc.
Argon Medical Devices, Inc.
Teleflex Incorporated
Cardinal Health, Inc.
ALN Implants Chirurgicaux

Product Code: SQMIG35A2557

Global Inferior Vena Cava Filters Market size was valued at USD 783.6 million in 2022 and is poised to grow from USD 849.66 million in 2023 to USD 1623.45 million by 2031, growing at a CAGR of 8.43% in the forecast period (2024-2031).

The market for inferior vena cava (IVC) filters plays a crucial role in averting life-threatening situations associated with blood clots by intercepting them before they reach the lungs. These medical devices are inserted into the inferior vena cava, the primary vein transporting deoxygenated blood from the lower body to the heart, with the purpose of trapping blood clots and reducing the risk of pulmonary embolism. The market's expansion is fueled by the escalating prevalence of venous thromboembolism (VTE) and deep vein thrombosis (DVT) cases, alongside heightened awareness of these conditions. Various factors such as an aging demographic, sedentary lifestyles, and surgical interventions contribute to the heightened clotting risk, thereby boosting demand for IVC filters. Technological advancements, including retrievable and adjustable filter designs, augment their effectiveness and safety, thereby driving market growth. Moreover, the market benefits from the increasing adoption of minimally invasive procedures and advancements in medical imaging techniques, facilitating precise filter placement. North America dominates the market, thanks to its robust healthcare infrastructure and high incidence of VTE cases, while the Asia-Pacific region experiences rapid growth due to rising healthcare expenditure and awareness. Europe also holds a significant market share due to its aging population. With ongoing innovation in IVC filter technologies and their increasing adoption among high-risk patients, the market is well-positioned to address the critical necessity of preventing blood clot-related complications and enhancing patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Inferior Vena Cava Filters Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Inferior Vena Cava Filters Market Segmental Analysis

The global inferior vena cava filters market is segmented by Product Type, Placement, End User, and Region. Based on Product Type the market is segmented as, Retrievable Filters, and Permanent Filters. Based on Placement the market is Permanent Placement, Temporary Placement. Based on End-User the market is segmented as, Hospitals, Ambulatory Surgical Centers. Regional the market is segmented as, North America, Asia Pacific, Latin America, and Middle East & Africa (MEA).

Drivers of the Global Inferior Vena Cava Filters Market

The escalating incidence of venous thromboembolism (VTE) incidents, encompassing both deep vein thrombosis (DVT) and pulmonary embolism (PE), underscores the necessity for inferior vena cava filters as proactive interventions. With sedentary lifestyles, prolonged immobility, and certain medical conditions predisposing individuals to VTE, the implementation of these filters serves as a crucial preventive measure against potentially life-threatening complications. As the healthcare landscape continues to evolve, the development of advanced filter technologies and their accessibility in diverse healthcare settings becomes imperative in addressing this growing healthcare concern.

Restraints in the Global Inferior Vena Cava Filters Market

The insertion of an inferior vena cava (IVC) filter may result in complications such as migration, fracture, and perforation, prompting apprehensions regarding the enduring safety and effectiveness of such devices. These concerns underscore the importance of vigilant monitoring and thorough assessment of patients who have undergone IVC filter placement. Moreover, ongoing research endeavors are essential to continually refine these interventions and enhance patient outcomes, emphasizing the imperative for collaborative efforts between medical practitioners and researchers in this field.

Market Trends of the Global Inferior Vena Cava Filters Market

There's a notable trend in the market favoring retrievable filters, propelled by their adaptable nature and the promise of easy removal, which resonates with the ethos of patient-centered healthcare and the imperative to mitigate long-term hazards. This shift underscores a growing recognition within the medical community of the importance of interventions that can be tailored to individual patient needs while also prioritizing safety and long-term well-being. Additionally, retrievable filters offer a dynamic solution for addressing evolving patient conditions, serving as a proactive measure in minimizing potential complications associated with prolonged implantation.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Inferior Vena Cava Filters Market by Product Type

Market Overview
Retrievable Filters and Permanent Filters

Global Inferior Vena Cava Filters Market by Placement

Market Overview
Permanent Placement
Temporary Placement

Global Inferior Vena Cava Filters Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cordis Corporation (a Cardinal Health company)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
C.R. Bard, Inc. (acquired by BD)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Argon Medical Devices, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ALN Implants Chirurgicaux
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments